Category: Ebola Virus

Circulating vaccine-derived poliovirus type 1 – Myanmar

On 23 June 2019, a vaccine-derived poliovirus type 1 (VDPV1) was isolated from a two -year- old child with acute flaccid paralysis (AFP), with onset of paralysis on 22 May 2019 from Kayin state, Myanmar. Subsequently, on 11 July 2019, a genetically linked VDPV1 was isolated from the same state from a 5-year 6-month-old child

Ebola virus disease – Democratic Republic of the Congo

The Ebola virus disease (EVD) outbreak in North Kivu and Ituri provinces in the Democratic Republic of the Congo continued this week with similar transmission intensity to recent weeks, with an average of 81 cases per week (range 68 to 91 cases per week) in the past six weeks (Figure 1).

Existing anti-parasitic drug could offer treatment for Ebola

Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection. In meticulous experiments in human cells, the drug significantly amplified immune responses to Ebola and inhibited Ebola replication.

Ebola virus disease – Democratic Republic of the Congo

The Ebola virus disease (EVD) outbreak in North Kivu and Ituri provinces in the Democratic Republic of the Congo continued this week with similar transmission intensity to recent weeks with an average of 86 cases per week (range 80 to 91 cases per week) in the past six weeks (Figure 1).

Ebola virus disease – Democratic Republic of the Congo

The Ebola virus disease (EVD) outbreak in North Kivu and Ituri provinces in the Democratic Republic of the Congo continued this week with similar transmission intensity to recent weeks, with an average of 85 cases per week (range 79 to 91 cases per week) in the past six weeks (Figure 1).

Circulating vaccine-derived poliovirus type 2 – African Region

The summaries below provide a situational update on circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the WHO African and Eastern Mediterranean regions. No wild poliovirus has been detected on the African continent since September 2016. In the Lake Chad Basin (LCB) sub-region, multiple cVDPV2 outbreaks continue to spread. All the countries that comprise the